Blood Biomarker Linked to Incident VTE in COVID-19 Patients - HealthDay News
8/22/2022 12:00:00 AM2 years 8 months ago
by Physician’s Briefing Staff
by Physician’s Briefing Staff
Higher levels of soluble urokinase plasminogen activator receptor linked to incident venous thromboembolism independently of D-dimer
MONDAY, Aug. 22, 2022 (HealthDay News) -- Higher levels of soluble urokinase plasminogen activator receptor (suPAR) are associated with incident venous thromboembolism (VTE) among patients hospitaliz… [+1672 chars]
full article...